These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Selective deoxygenation and modification at C2' of nucleosides.
    Author: Robins MJ.
    Journal: Nucleic Acids Symp Ser; 1982; (11):1-4. PubMed ID: 7183953.
    Abstract:
    Treatment of nucleosides with 1,1,3,3-tetraisopropyl-1,3-dichlorodisiloxane in pyridine gives the 3',5'-O-(1,1,3,3-tetraisopropyldisilox-1,3-diyl) derivatives in high yields. These selectively protected 3',5'-O-TPDS-nucleosides can be functionalized readily at 02'. Deoxygenation of beta-ribonucleosides affords the 2'-deoxy-beta-D-erythro-pentofuranosyl compounds. Analogous treatment of alpha-arabinonucleosides provides a stereoselective route to the 2'-deoxy-alpha-D-erythro-pentofuranosyl products. Sequential oxidation and reduction of 3',5'-O-TPDS-beta-ribonucleosides gives the beta-arabinonucleosides. Triflation followed by nucleophilic displacements converts 3',5'-O-TPDS-ribo and arabinonucleosides to their corresponding 2'-deoxy-2'-substituted arabino and ribo analogues, respectively.
    [Abstract] [Full Text] [Related] [New Search]